| Literature DB >> 25923316 |
Chang-Feng Chi1, Fa-Yuan Hu2, Bin Wang3, Zhong-Rui Li4, Hong-Yu Luo5.
Abstract
Influence of amino acid compositions and peptide profiles on antioxidant capacities of two protein hydrolysates from skipjack tuna (Katsuwonus pelamis) dark muscle was investigated. Dark muscles from skipjack tuna were hydrolyzed using five separate proteases, including pepsin, trypsin, Neutrase, papain and Alcalase. Two hydrolysates, ATH and NTH, prepared using Alcalase and Neutrase, respectively, showed the strongest antioxidant capacities and were further fractionated using ultrafiltration and gel filtration chromatography. Two fractions, Fr.A3 and Fr.B2, isolated from ATH and NTH, respectively, showed strong radical scavenging activities toward 2,2-diphenyl-1-picrylhydrazyl radicals (EC50 1.08% ± 0.08% and 0.98% ± 0.07%), hydroxyl radicals (EC50 0.22% ± 0.03% and 0.48% ± 0.05%), and superoxide anion radicals (EC50 1.31% ± 0.11% and 1.56% ± 1.03%) and effectively inhibited lipid peroxidation. Eighteen peptides from Fr.A3 and 13 peptides from Fr.B2 were isolated by reversed-phase high performance liquid chromatography, and their amino acid sequences were determined. The elevated antioxidant activity of Fr.A3 might be due to its high content of hydrophobic and aromatic amino acid residues (181.1 and 469.9 residues/1000 residues, respectively), small molecular sizes (3-6 peptides), low molecular weights (524.78 kDa), and amino acid sequences (antioxidant score 6.11). This study confirmed that a smaller molecular size, the presence of hydrophobic and aromatic amino acid residues, and the amino acid sequences were the key factors that determined the antioxidant activities of the proteins, hydrolysates and peptides. The results also demonstrated that the derived hydrolysates and fractions from skipjack tuna (K. pelamis) dark muscles could prevent oxidative reactions and might be useful for food preservation and medicinal purposes.Entities:
Mesh:
Substances:
Year: 2015 PMID: 25923316 PMCID: PMC4446595 DOI: 10.3390/md13052580
Source DB: PubMed Journal: Mar Drugs ISSN: 1660-3397 Impact factor: 5.118
Radical (DPPH•, HO•, and •) scavenging activities and the degree of hydrolysis (DH, %) of the protein hydrolysates of STDM using five proteases.
| Enzyme | DH (%) | EC50 (mg/mL) of Protein Hydrolysates | ||
|---|---|---|---|---|
| DPPH• | HO• | |||
| Pepsin | 22.93 ± 0.98 a | 7.09 ± 0.37 a | 2.37 ± 0.09 a | 7.65 ± 0.42 a |
| Trypsin | 19.35 ± 0.67 b | 9.36 ± 0.51 b | 4.09 ± 0.16 b | 9.37 ± 0.40 b |
| Neutrase | 25.72 ± 1.09 c | 5.38 ± 0.15 c | 1.58 ± 0.11 c | 6.38 ± 0.53 c |
| Papain | 21.23 ± 0.83 a | 8.65 ± 0.57 b | 3.42 ± 0.23 d | 8.66 ± 0.48 b |
| Alcalase | 27.63 ± 1.14 d | 4.54 ± 0.43 d | 1.27 ± 0.12 e | 5.67 ± 0.26 c |
All values were the mean ± standard deviation (SD). EC50 (mg/mL) was defined as the concentration at which a sample caused a 50% decrease in the initial concentrations of DPPH•, HO•, and •. (a–e) Values with different letters indicated significant differences in the same sample at different times (p < 0.05).
Figure 1DH of protein hydrolysates of STDM using five proteases. All values mean ± SD. (a–e) Values with different letters indicated significant differences in the same sample at different times (p < 0.05); (A–D) Values with different letters indicated significant differences in different samples at the same time (p < 0.05).
Radical (DPPH•, HO•, and •) scavenging activities of protein hydrolysates (ATH and NTH) and their fractions prepared by ultrafiltration and gel filtration chromatography.
| Sample | EC50 (mg/mL) | ||
|---|---|---|---|
| DPPH• | HO• | ||
| 4.54 ± 0.43 a | 1.27 ± 0.12 a | 5.67 ± 0.26 a | |
| 7.06 ± 0.63 b | 1.56 ± 0.17 b | 6.82 ± 0.47 b | |
| 2.21 ± 0.12 c,f | 0.58 ± 0.05 c,d | 2.74 ± 0.11 c | |
| 3.27 ± 0.24 d,e | 0.73 ± 0.08 d,e | 3.54 ± 0.26 d | |
| 2.42 ± 0.15 f | 0.55 ± 0.06c,d,f | 2.76 ± 0.18 c | |
| 1.08 ± 0.08 g | 0.22 ± 0.05 g | 1.31 ± 0.11 e | |
| 1.76 ± 0.04 c | 0.37 ± 0.03 f,g | 1.69 ± 0.09 e | |
| 5.38 ± 0.15 h | 1.58 ± 0.11 b | 6.38 ± 0.53 b | |
| 8.16 ± 0.42 i | 1.88 ± 0.22 h | 7.34 ± 0.58 f | |
| 3.09 ± 0.23 d | 0.85 ± 0.06 e,i | 2.83 ± 0.18 c | |
| 3.74 ± 0.24 e | 1.09 ± 0.12 j | 3.36 ± 0.32 d | |
| 0.98 ± 0.07 g | 0.48 ± 0.05 c,f | 1.56 ± 0.13 e | |
| 3.06 ± 0.15 d | 0.94 ± 0.06 i,j | 2.35 ± 0.22 c | |
All values were the mean ± standard deviation (SD). EC50 (mg/mL) was defined as the concentration at which a sample caused a 50% decrease in the initial concentrations of DPPH•, HO•, and •. (a–j) Values with different letters indicated significant differences in the same sample at different times (p < 0.05).
Figure 2Elution profiles of ATH-II (A) and NTH-II (B) obtained by size exclusion chromatography on a Sephadex G-25 column.
Amino acid compositions of Defatted STDM, ATH, NTH, Fr.A3 and Fr.B2 (expressed as residues/1000 residues).
| Amino Acid | Defatted STDM | ATH | NTH | Fr.A3 | Fr.B2 |
|---|---|---|---|---|---|
| Asp (D) | 98.2 | 96.9 | 97.3 | 79.9 | 91.2 |
| Glu (E) | 127.6 | 125.2 | 125.7 | 94.0 | 106.9 |
| Ser (S) | 71.4 | 70.5 | 70.8 | 65.2 | 60.8 |
| Gly (G) | 79.6 | 76.8 | 77.3 | 63.8 | 69.6 |
| His (H) | 75.4 | 74.7 | 74.6 | 81.1 | 73.9 |
| Arg (R) | 69.7 | 70.2 | 68.9 | 53.6 | 61.9 |
| Thr (T) | 48.5 | 47.7 | 48.3 | 36.5 | 41.2 |
| Cys (C) | 3.9 | 4.1 | 4.5 | 6.4 | 5.5 |
| Tyr (Y) | 11.3 | 11.7 | 12.6 | 24.0 | 22.5 |
| Lys (K) | 29.6 | 30.2 | 29.5 | 25.6 | 29.1 |
| Ala (A) | 79.4 | 80.1 | 80.5 | 89.8 | 86.1 |
| Pro (P) | 9.7 | 9.4 | 9.2 | 14.9 | 10.6 |
| Val (V) | 72.4 | 73.6 | 73.1 | 85.4 | 81.7 |
| Met (M) | 24.7 | 25.6 | 25.3 | 21.2 | 20.0 |
| Ile (I) | 53.9 | 54.7 | 53.4 | 78.7 | 70.1 |
| Leu (L) | 94.3 | 96.3 | 97.1 | 103.9 | 92.5 |
| Trp (W) | 10.8 | 12.4 | 11.6 | 26.4 | 21.9 |
| Phe (F) | 39.6 | 39.9 | 40.3 | 49.6 | 54.5 |
| Total | 1000 | 1000 | 1000 | 1000.0 | 1000.0 |
| Aromatic amino acids | 137.1 | 138.7 | 139.1 | 181.1 | 172.8 |
| Hydrophobic amino acids | 384.8 | 392 | 390.5 | 469.9 | 437.4 |
Figure 3Elution profiles of Fr.A3 (A) and Fr.B2 (B) obtained by RP-HPLC on a Zorbax SB-C18 column (4.6 mm × 250 mm, Agilent, USA). Absorbance was measured at 220 nm.
Potential antioxidant peptides and their antioxidant scores from Fr.A3 and Fr.B2, as identified by Procise Protein/Peptide Sequencer and ESI-MS.
| No. | Retention Time (min) | Observed Mass (Da) | Calculated Mass (Da) | Amino Acid Sequence | Antioxidant Score |
|---|---|---|---|---|---|
| A01 | 13.733 | 335.33 | 335.36 | YGP | 5.5 |
| A02 | 16.266 | 482.42 | 482.44 | YEGD | 4.5 |
| A03 | 16.806 | 463.53 | 463.55 | QWM | 7.5 |
| A04 | 20.310 | 538.50 | 538.51 | EYNN | 4 |
| A05 | 22.248 | 423.41 | 423.42 | QNY | 4.5 |
| A06 | 22.897 | 331.30 | 331.33 | QAGG | 2 |
| A07 | 24.510 | 429.45 | 429.47 | QPW | 8.5 |
| A08 | 26.176 | 407.41 | 407.42 | QFN | 3 |
| A09 | 30.586 | 660.69 | 660.72 | DVIEW | 9.5 |
| A10 | 34.303 | 902.91 | 902.9 | QYDEYW | 9.5 |
| A11 | 34.731 | 574.64 | 574.67 | WVGTI | 9.5 |
| A12 | 36.096 | 563.57 | 563.60 | DLYPG | 5 |
| A13 | 42.855 | 571.61 | 571.62 | YVAGY | 6 |
| A14 | 43.706 | 489.49 | 489.52 | DVWA | 8 |
| A15 | 47.132 | 528.58 | 528.60 | QPVW | 9.5 |
| A16 | 49.811 | 681.73 | 681.74 | QELHR | 3 |
| A17 | 54.420 | 619.69 | 619.71 | EYIPV | 7.5 |
| A18 | 58.529 | 441.45 | 441.48 | QPPT | 3 |
| B01 | 8.040 | 446.39 | 446.41 | QGGEG | 2 |
| B02 | 13.935 | 538.48 | 538.51 | YENGG | 4.5 |
| B03 | 14.673 | 506.44 | 506.46 | QESGS | 2 |
| B04 | 15.499 | 510.46 | 510.50 | QYSGG | 4 |
| B05 | 19.120 | 521.49 | 521.52 | EGYPG | 4 |
| B06 | 20.272 | 407.40 | 407.42 | QFGG | 3 |
| B07 | 20.631 | 494.48 | 494.50 | QFGGS | 3 |
| B08 | 21.208 | 464.45 | 464.47 | QFGGG | 3 |
| B09 | 23.477 | 681.73 | 681.74 | WGYAW | 10 |
| B10 | 29.739 | 742.83 | 742.86 | YIVYW | 12 |
| B11 | 31.753 | 1214.21 | 1214.24 | WGDAGGYYYY | 10 |
| B12 | 34.311 | 544.62 | 544.64 | QILTA | 3 |
| B13 | 36.043 | 543.54 | 543.57 | QPWN | 8 |
Figure 4Lipid peroxidation inhibition assays of Fr.A3 and Fr.B2 in a linoleic acid oxidation system over seven days. The degree of linoleic acid oxidation was assessed by measuring the optical density at 500 nm at 24-h intervals. Glutathione was used as the positive control.